Standout Papers

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-an... 2006 2026 2012 2019 4.3k
  1. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials (2010)
    Colin Baigent, Lisa Blackwell et al. The Lancet
  2. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies (2009)
    Gary Whitlock, Sarah Lewington et al. The Lancet
  3. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis (2015)
    Dena Ettehad, Connor A. Emdin et al. The Lancet
  4. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths (2007)
    Sarah Lewington, Gary Whitlock et al. The Lancet
  5. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials (2006)
    Patricia M. Kearney, Colin Baigent et al. BMJ
  6. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials (2015)
    Jordan Fulcher, Rachel O’Connell et al. The Lancet
  7. Comparison of Risk Prediction Using the CKD-EPI Equation and the MDRD Study Equation for Estimated Glomerular Filtration Rate (2012)
    Kunihiro Matsushita, Bakhtawar K. Mahmoodi et al. JAMA
  8. A Randomized Controlled Trial of Exercise and Manipulative Therapy for Cervicogenic Headache (2002)
    Gwendolen Jull, Patricia Trott et al. Spine
  9. COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England (2020)
    Marion Mafham, Enti Spata et al. The Lancet
  10. Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59 124 patients (2023)
    Natalie Staplin, Alejandro de la Sierra et al. The Lancet

Immediate Impact

5 from Science/Nature 166 standout
Sub-graph 1 of 16

Citing Papers

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
2023 Standout
Empagliflozin in Patients with Chronic Kidney Disease
2022 Standout
44 intermediate papers

Works of Jonathan Emberson being referenced

Net effects of sodium-glucose co-transporter-2 inhibition in different patient groups: a meta-analysis of large placebo-controlled randomized trials
2021
Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials
2016
and 15 more

Author Peers

Author Last Decade Papers Cites
Jonathan Emberson 6146 7590 3963 133 20.3k
Ingar Holme 6683 9306 5116 310 24.9k
Luther T. Clark 7315 8448 7311 99 21.8k
Guy De Backer 11963 7343 5489 295 23.5k
James M. McKenney 4894 10019 7409 154 20.7k
Donald B. Hunninghake 7363 11083 9241 167 25.9k
Amit Khera 9594 6317 4625 206 21.5k
D. Roger Illingworth 4042 6854 6205 162 17.8k
Karol E. Watson 7711 7939 4334 211 22.0k
Patrick E. McBride 12313 10309 7646 113 29.3k
Thomas A. Pearson 9708 6743 4840 289 27.1k

All Works

Loading papers...

Rankless by CCL
2026